Trendlines set to raise $17.6m in Singapore IPO

medicine

The Israeli technological incubator hopes to become the second Israeli company on the Singapore Stock Exchange, after Sarin Technologies.

Israeli technological incubator Trendlines Group has launched a S$25 million ($17.6 million) IPO on the Singapore Stock Exchange. Trendlines develops early stage companies in the medical and agricultural sectors.

Trendlines, which hopes to be trading by November 26, hope to become the second Israeli company on the Singapore Stock Exchange, after Sarin Technologies, which produces tools for the diamond industry.

Trendlines chairman and CEO Steve Rhodes said, “We thought that we were too small for NASDAQ so we started looking for other markets. The one that fit our size and stage best was Singapore.

The company had planned an IPO in Toronto in September 2014 but withdrew because of insufficient investor interest.

Trendlines is offering 75.7 million shares at S$0.33 apiece, the proceeds of which will be used to invest in incubators, make follow-up investments in existing companies and start new companies, Trendlines said yesterday. The offer closes Nov 24.

Rhodes said: “We have been working as a private company for the last eight years. We have gone from zero to being a company with a large portfolio with a growing value and we felt that it was time to bring in a lot of capital and scale what we were doing and to start looking at international expansion.”

In addition to the IPO, the company will set up an incubator in Singapore by next year with about six employees and Trendlines is in talks with local partners on the matter.

Published by Globes [online], Israel business news - www.globes-online.com - on November 17, 2015

© Copyright of Globes Publisher Itonut (1983) Ltd. 2015

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2016